Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Patients without CHD were older (mean age 71.5 years) than those with DV-CHD (mean age 59.8

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4136694-A4136694, November 12, 2024. Background:Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is used to treat cardiogenic shock. to 1.36) but not in VA-ECMO with IABP (1.80 to 1.96) and VA-ECMO alone (1.94

Cardiogenic Shock 40

Cardiogenic Shock Pulmonary Aortic Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4143363-A4143363, November 12, 2024. Background:Various temporary mechanical circulatory support device (t-MCS) options are available for supporting patients in cardiogenic shock.

Cardiogenic Shock 40

Cardiogenic Shock Cancer Heart Failure Physiology 40

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

The VSR is what is causing the cardiogenic shock! Mechanical complications occur acutely and significantly alter hemodynamics leading to comp ensatory mechanism which usually involve vasoconstriction and tachycardia, both hallmarks of cardiogenic shock. PIRP is strongly associated with myocardial rupture. Hammill SC.

Cardiogenic Shock 109

Cardiogenic Shock Pericarditis Chest Pain Myocardial Infarction 109

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142969-A4142969, November 12, 2024. Background:Temporary mechanical circulatory support devices (t-MCS) facilitate recovery of the patients, to then bridge them to cardiac replacement. A new paradigm of resting and recovering the heart with a t-MCS device is being explored.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Aortic Circulation 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4118341-A4118341, November 12, 2024. There was a non-significant increased risk of cardiogenic shock (aOR 1.14, 95% CI 0.87 - 1.5, Background:Opioid use has increased significantly in the past few decades, impacting cardiac and non-cardiac patients.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Inpatient Cardiogenic Shock Heart Failure 40